12th December 2024
07:00

Avacta Group PLC - Completion of Dose Escalation and RDE Arms

30th October 2024
07:00

Avacta Group PLC - R&D Spotlight focusing on pipeline advances

28th October 2024
07:00

Avacta Group PLC - Block Listing Six Monthly Return

24th October 2024
06:00

Avacta Group PLC - Avacta Reports Pipeline Avances at EORTC

21st October 2024
15:00

Avacta Group PLC - Issue of Equity and Total Voting Rights

21st October 2024
06:00

Avacta Group PLC - Avacta and Tempus Enter Strategic Collaboration

17th October 2024
06:00

Avacta Group PLC - Avacta Expands its Pipeline

15th October 2024
06:00

Avacta Group PLC - Avacta appoints Chief Scientific Officer

10th October 2024
06:00

Avacta Group PLC - Avacta Unveils Pipeline Expansion at EORTC 2024

30th September 2024
06:00

Avacta Group PLC - Interim Results

16th September 2024
06:00

Avacta Group PLC - Avacta Reported Updated Phase 1 Data of AVA6000

12th September 2024
06:00

Avacta Group PLC - Notice of Results

9th September 2024
06:00

Avacta Group PLC - Avacta to present clinical data at ESMO Congress

2nd September 2024
14:53

Avacta Group PLC - Director/PDMR Shareholdings and TVR

18th July 2024
06:00

Avacta Group PLC - Convertible Bond Payment

26th June 2024
13:46

Avacta Group PLC - Result of AGM

Avacta Group Plc (AVCT.L) Share Price & News

Bid

-

-

-

Ask

High
-
OPEN
-
VOL
-
MKT CAP
-M

LOW
-
CLOSE
-
SHARES IN ISSUE
350.51M

Avacta Group Plc Company Profile

Avacta is a healthcare group developing innovative cancer drugs and powerful in vitro diagnostics to improve human health and well-being.

Featured Media

Watchlist